Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126996
Filing Date
2024-11-14
Accepted
2024-11-14 15:49:19
Documents
82
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ttoo-20240930.htm   iXBRL 10-Q 2737471
2 EX-10.1 ttoo-ex10_1.htm EX-10.1 29483
3 EX-10.2 ttoo-ex10_2.htm EX-10.2 25785
4 EX-10.3 ttoo-ex10_3.htm EX-10.3 24654
5 EX-31.1 ttoo-ex31_1.htm EX-31.1 15126
6 EX-31.2 ttoo-ex31_2.htm EX-31.2 15118
7 EX-32.1 ttoo-ex32_1.htm EX-32.1 7043
8 EX-32.2 ttoo-ex32_2.htm EX-32.2 7233
  Complete submission text file 0000950170-24-126996.txt   11965588

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ttoo-20240930.xsd EX-101.SCH 1868725
84 EXTRACTED XBRL INSTANCE DOCUMENT ttoo-20240930_htm.xml XML 2052563
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36571 | Film No.: 241461223
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)